UnknownNot Applicable

Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer

China630 participantsStarted 2014-09

Plain-language summary

The purpose of this study is to compare early-stage peripheral non-small cell lung cancer lobectomy and sub-lobectomy surgery to evaluate if sub-lobectomy is as feasible and effective for the treatment of early-stage (diameter ≤2cm) peripheral non-small cell lung cancer as lobectomy.

Who can participate

Age range60 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. clinically diagnosed with stage I peripheral non-small cell lung cancer suitable for lobectomy.
✓. T≤2cm，N0，M0.
✓. aged 60 to 80 years old.
✓. ECOG≤2.
✓. according to the Ministry of Health, "with primary lung cancer diagnostic and treatment practices" (2011 edition) completed preoperative clinical staging examination.
✓. voluntary participation, signed informed consent.

Exclusion criteria

✕. pathologic stage is N1, N2, or M1a.
✕. received postoperative adjuvant therapy (chemotherapy or targeted therapy).
✕. radiotherapy or chemotherapy before surgery.
✕. small cell lung cancer
✕. benign lesions
✕. patient unwilling to cooperate with surgery or observation.

What they're measuring

Disease-free survival

Timeframe: participants will be followed from surgical treatment at least 5 years unless any evidence of disease progression or death

Trial details

NCT IDNCT02288026

SponsorCapital Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-12

Contact for this trial

Xiuyi Zhi

+86 10 83198287

View on ClinicalTrials.gov More Stage IA Non-small Cell Lung Cancer trials